Clover health investments, corp. CLOV.US Overview
BetaUS StockHealthcare
(No presentation for CLOV)
CLOV AI Analysis & Strategy
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
CLOV Current Performance
-1.16%
Clover health investments, corp.
0.98%
Avg of Sector
0.83%
S&P500
CLOV Key Information
CLOV Financial Forecast
Unit : USD
CLOV Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | 0.05 | 200% | -171.4% | 462.33M | 33.3% | -1% | -6.6% |
| 2024Q3 | -0.04 | 66.7% | -42.9% | 336.96M | -34% | -3% | -2.8% |
| 2024Q2 | -0.02 | 77.8% | 50% | 330.99M | 8.2% | -4.9% | 2.1% |
| 2024Q1 | 0.01 | 116.7% | -120% | 356.26M | 11.3% | 5.2% | -5.5% |
| 2023Q4 | -0.05 | 66.7% | -28.6% | 346.92M | 7.7% | 8% | -13.8% |
CLOV Profile
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.